The Patent Finder

Allianz Pharmascience Ltd.

Also on record
Records under this name other than patents Allianz Pharmascience Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Allianz Pharmascience Ltd.

PatentTitleStatus Expires Confidence
US 8,710,272Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,000,222Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,259,402Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyI)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,562,025Compounds with (1E, 6E)-1,7-Bis-(3,4-dimethoxyphenyl)-4-4-distributed-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,202,905Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,236,852Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,135,185Uses of curcumin derivative
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,413,256Method for treating a neurodegenerative disorder
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,359,279Treatment of cancer, inflammatory disease, and autoimmune disease
Lapsed on the fee record
Ended Jun 7, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 7, 2024From the USPTO record
US 8,822,7321,5-diphenyl-penta-1,4-dien-3-one compounds
Lapsed on the fee record
Ended Sep 2, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 2, 2022From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited